From Kobe to the rest
of the world
Heralding a new era in healthcare
through trans-sector alliances
Foundation for Biomedical Research and Innovation at Kobe
In April 2018, our Foundation changed its official name, notably in Japanese, including in it the mention of “Kobe Biomedical Innovation Cluster.”
-
2025.02.03 Pressrelease
"Selenoprotein-Mediated Redox Regulation Shapes the Cell Fate of HSCs and Mature Lineages” : our research team’s findings published in Blood Online on February 1, 2025 -
2024.05.17 Pressrelease
X-irradiated umbilical cord blood cells retain their regenerative effect in experimental stroke: FBRI's research team’s findings published in Scientific Reports March 22, 2024 -
2024.04.01
Shuh Narumiya, M.D., Ph.D., appointed as the President of the Foundation for Biomedical Research and Innovation at Kobe (FBRI) and Hisashi Ietsugu, Sysmex Corporation Chairperson and Group CEO, appointed as the FBRI’s newly created position of the Chairman -
2024.03.28 Pressrelease
We have executed a collaborative research agreement for vascular regeneration products derived from human hematopoietic stem cells by Celaid Therapeutics
The foundation for Biomedical Research and Innovation at Kobe (FBRI) is the pivotal organization that promoters and facilitate collaboration and Integration among industrial, govern mental , academic and medical sectors.
The FBRI’s ultimate goals are to revitalize Kobe’s economy, enhance local residents’ wellbeing, and contribute to the international community.
From a devastating earthquake to a brighter futureKobe Biomedical Innovation Cluster
On January 17, 1995, the Great Hanshin-Awaji Earthquake struck Kobe. Severely damaged and realizing anew the preciousness of life, Kobe pledged to not simply reconstruct itself in economic terms but to do so by becoming a place where life is cherished above all. The city thus launched the project to develop a prime hub of healthcare research and related services.
Kobe Biomedical Innovation Cluster Top page
